Levey J A, Barrand M A, Callingham B A, Hider R C
Department of Chemistry, University of Essex, Colchester, U.K.
Biochem Pharmacol. 1988 May 15;37(10):2051-7. doi: 10.1016/0006-2952(88)90556-4.
Accumulation of radioactive iron (59Fe) into isolated fragments of rat small intestine in the presence of two hydroxypyrones, maltol and ethyl maltol, was compared with that in the presence of another chelator of iron(III), nitrilotriacetic acid (NTA). The characteristics of uptake were similar with all three ligands. Between 10(-6) and 10(-4) M, iron uptake showed saturable kinetics. The uptake was partially inhibited by metabolic inhibitors. Above 10(-4) M a non-saturable uptake, unaffected by metabolic inhibitors became evident in the presence of the pyrones. The distribution of 59Fe after uptake was determined by gel filtration. At low iron concentrations (10(-6) M), 35-40% of absorbed iron was associated with proteins of molecular weights similar to those of ferritin and transferrin. At high concentrations (10(-3) M), the majority of 59Fe was found in a low molecular weight fraction. At each concentration, a small amount of 59Fe was bound to a membrane fraction. 5% Polyethylene glycol, which reduces glycocalyx viscosity enhanced uptake at low iron concentrations (10(-6) M) but did not affect the non-saturable diffusion seen at higher concentrations (10(-3) M). The iron(II) chelator, bathophenanthroline sulphonate (10(-3) M), decreased uptake at low iron concentrations but did not affect the non-saturable uptake. It is suggested that conversion of iron(III) to iron(II) may take place at the mucosal cell surface before uptake via the saturable system. Apparent Km values for iron uptake via the saturable system were higher in the presence of maltol and ethyl maltol than in the presence of NTA, presumably since the iron binds more avidly to the hydroxypyrones and so is less readily donated. Excess ligand, either pyrone or NTA, reduced the rate at which 59Fe was donated to the uptake system. The Vmax value for uptake from the pyrones was greater than from NTA. It is concluded that maltol, ethyl maltol and NTA can hold iron(III) in solution and donate it to an endogenous uptake system. But, the hydroxypyrones may be more suitable ligands for the oral administration of iron since, when complexed with iron, they lack the toxic effects associated with iron(III)-NTA and with iron(II) preparations.
在两种羟基吡喃酮(麦芽酚和乙基麦芽酚)存在的情况下,将放射性铁(59Fe)在大鼠小肠分离片段中的积累情况与在另一种铁(III)螯合剂次氮基三乙酸(NTA)存在的情况下进行了比较。三种配体的摄取特征相似。在10^(-6)至10^(-4)M之间,铁摄取呈现出饱和动力学。摄取受到代谢抑制剂的部分抑制。在10^(-4)M以上,在吡喃酮存在下,一种不受代谢抑制剂影响的非饱和摄取变得明显。摄取后59Fe的分布通过凝胶过滤来确定。在低铁浓度(10^(-6)M)下,35 - 40%吸收的铁与分子量与铁蛋白和转铁蛋白相似的蛋白质相关。在高铁浓度(10^(-3)M)下,大部分59Fe存在于低分子量部分。在每个浓度下,少量59Fe与膜部分结合。5%的聚乙二醇可降低糖萼粘度,在低铁浓度(10^(-6)M)下增强摄取,但不影响在较高浓度(10^(-3)M)下看到的非饱和扩散。铁(II)螯合剂4,7 - 二苯基 - 1,10 - 菲咯啉磺酸(10^(-3)M)在低铁浓度下降低摄取,但不影响非饱和摄取。这表明在通过饱和系统摄取之前,铁(III)可能在黏膜细胞表面转化为铁(II)。在麦芽酚和乙基麦芽酚存在下,通过饱和系统摄取铁的表观Km值高于在NTA存在下,推测是因为铁与羟基吡喃酮结合更紧密,因此不太容易被释放。过量的配体,无论是吡喃酮还是NTA,都会降低59Fe被提供给摄取系统的速率。来自吡喃酮的摄取Vmax值大于来自NTA的。结论是麦芽酚、乙基麦芽酚和NTA可以将铁(III)保持在溶液中并将其提供给内源性摄取系统。但是,羟基吡喃酮可能是更适合口服铁的配体,因为当与铁络合时,它们缺乏与铁(III) - NTA和铁(II)制剂相关的毒性作用。